The present application describes compounds according to Formula I, pharmaceutical compositions comprising at least one compound according to Formula I and optionally one or more additional therapeutic agents and methods of treatment using the compounds according to Formula I both alone and in combination with one or more additional therapeutic agents. The compounds have the general Formula I: ##STR00001## including all prodrugs, pharmaceutically acceptable salts and stereoisomers, R.sup.1, R.sup.2, R.sup.3, n, and Z are described herein.

 
Web www.patentalert.com

< Non-destructive systems, devices, and methods for evaluating iontophoresis drug delivery devices

< Lysine salts of 4-((phenoxyalkyl)thio)-phenoxyacetic acid derivatives

> KSR2 knockout mice and methods of use thereof

> Inhibitors of AKT activity

~ 00603